Tempus AI Stock (TEM) Hits New 52-Week despite Analyst Downgrade
Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...
Artera partners with Tempus to expand AI cancer test access
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Tempus AI enters collaboration with Institute for Follicular Lymphoma Innovation
Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Le Lézard1d
Artera Announces Collaboration with Tempus to Expand Access to Personalized Prostate Cancer Treatment
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, a technology company leading the adoption of AI to advance precision ...
Finbold | Finance in Bold2d
If you put $1,000 into Tempus AI stock when Nancy Pelosi bought, here’s your return now
Regarding the transaction, the lawmaker disclosed on January 14 the accumulation of 50 call options in Tempus AI with a ...
Le Lézard2d
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025.
Tempus AI's chief legal officer Erik Phelps sells shares worth $400,960
Erik Phelps, the Executive Vice President and Chief Administrative and Legal Officer of Tempus AI , Inc. (NASDAQ:TEM), ...
Tempus AI CFO Rogers sells shares worth $588,669
James William Rogers (NYSE:ROG), the Chief Financial Officer of Tempus AI , Inc. (NASDAQ:TEM), recently sold 8,712 shares of the company’s Class A common stock. The shares were sold at a weighted ...